Related Experiment Video

Updated: Jun 23, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

5.9K

NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

Duo Xu1, Shiyuan Yin1, Yongqian Shu2

  • 1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

NPJ Precision Oncology
|June 15, 2024
PubMed

Insights

Neurofibromatosis type 2 (NF2) gene inactivation drives tumor development. This review explores NF2

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neurofibromatosis type 2 (NF2) encodes the merlin protein, a tumor suppressor involved in regulating cell signaling pathways.
  • NF2 mutations are linked to various tumors, including mesothelioma, schwannomas, and meningioma.
  • The precise role of NF2 in tumorigenesis and the impact of cross-cancer mutations remain incompletely understood.

Purpose of the Study:

  • To consolidate current knowledge on the biological roles of the NF2 gene in cancer.
  • To examine the interplay between cancer metabolism and tumor immunity in merlin-deficient malignancies.
  • To identify potential therapeutic strategies for NF2-associated tumors.

Main Methods:

  • Literature review and synthesis of existing research on NF2.
  • Analysis of studies investigating metabolic and immunological features of NF2-deficient tumors.
  • Exploration of genetic codeficiencies (e.g., CDKN2A/B, BAP1, LATS2) and their impact on tumor characteristics.

Main Results:

  • NF2 inactivation affects multiple signaling pathways (Hippo, mTOR, RAS, cGAS-STING).
  • Codeficiencies in genes like CDKN2A/B, BAP1, and LATS2 contribute to unique tumor phenotypes.
  • Emerging evidence highlights the significance of metabolic reprogramming and immune evasion in NF2-related cancers.

Conclusions:

  • Understanding NF2's complex role in tumorigenesis is crucial for targeted therapies.
  • Investigating metabolic and immune interactions in merlin-deficient tumors offers novel therapeutic avenues.
  • This review provides a foundation for developing innovative treatment strategies for NF2-associated cancers.

More Related Videos

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

10.3K
Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

24.8K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.9K